biological therapy is an effective mean in increasing functional capacity and joint mobility, decreasing disease activity, improving quality of life for AS patients. Currently available data do not adequately address what role physiotherapy may have on patients with AS receiving biological drugs [1] . There are a few studies evaluating the effects of exercises in patients with AS receiving TNFa inhibitors [2, 3] . Methods: Patients were enrolled in a prospective study including 3 months of PT and 3 months of Y (with a specific focus on the control of breathingAi-jutsu). Each activity was performed bi-weekly in a dedicated facility. Patients were randomly allocated to either the group starting with PT or that starting with Y. After 3 months they switched to the other activity. At the beginning and at the end of each activity patients underwent a medical assessment of their physical status and were proposed questionnaires: 1) HAQ for disability in everyday life; 2) ZUNG self-rating depression scale; 3) Tampa scale for Kinesiophobia assessing the fear and avoidance of movement. Patients with FM compiled also the FIQ for the impact of FM in everyday life. All patients rated their physical pain by VAS (Visual Analogic Scale) from 0 to 10. Results: Thirteen patients with CA (77% female, median age 62 years, median disease duration 19 years) and 8 with FM (100% female, 56 years, 9 years) participated in the study. At baseline, there were no differences between CA and FM patients in terms of ZUNG, HAQ and Tampa scores. After 3 and 6 months of activity, all items had a tendency toward improvement, with a statistically significant reduction for VAS in both groups (nearly -30%). By intra-group comparison between the beginning and the end of each activity, we observed that patients with CA had a significant reduction of ZUNG and HAQ scores (50 vs 40.5 and 0.600 vs 0.475, respectively) during PT activity, while FM patients had a trend toward the increase of Tampa score (24.5 vs 34.5). During Y activity, significant reductions were observed in VAS score for CA patients (5 vs 2.5) and in Tampa score for FM patients (34.5 vs 23.5). Overall, all items had a tendency toward improvement for FM patients during Y activity.
Conclusions: This pilot study involving both patients with inflammatory and noninflammatory RD demonstrated benefit from an integrated program of sequential PT and Y and highlighted differences in patients' needs according to their disease type. Particularly, PT seemed to bring more benefit to CA patients, probably because of the individualized work on joint movement range and muscular strengthening, while FM patients may have had a negative impact by this approach, as seen by the increase in the fear of movement. Conversely, FM patients had a tendency toward improvement during Y activity. Acknowledgements: We thank the Patients Association (ABAR) for promoting and supporting the activities of this study and Essse Accademia for gently introducing our patients to the world of Yoga. 
Background:
The therapy for axial spondyloarthritis (axSpA) is complex. Although anti-inflammatory medication is necessary for axSpA treament, the exercise therapy is required to maintain mobility. The limited data are available to evaluate the effect of exercise therapy on quality of life in axSpA, particularly in patients with the non-radiographic form of the disease (nr-axSpA). Objectives: To investigated the quality of life in axSpA subgroups, nr-axSpA and Ankylosing spondylitis (AS) in response to intensive rehabilitation programme Methods: 46 patients with axSpA characterised according to criteria of Assessment of SpondyloArthritis international Society (ASAS) as nr-axSpA (n=23) and AS (n=23) with stable disease and treatment underwent 24 weeks long intervention. The intervention consisted in twice a week outpatient group physiotherapy as exercise units of 60 minutes and a daily home-based exercise programme. All outcomes, disease activity (Bath AS Disease Activity Index, BASDAI and AS Disease Activity Index, ASDAS-CRP) and quality of life (AS quality of life, ASQoL and European quality of life, EurQoL) as well as patients self-reported outcomes such as "patients global assessment" and "pain assessment" were measured at baseline and at the end of exercise program. Results: Altogether, 41 axSpA patients (AS, n=22 and nr-axSpA, n=19) finished complete six months programme. The disease activity was improved in all axSpA patients (ASDAS-CRP 2.08±0.12 to 1.83±0.11, p<0.01), particularly in nr-axSpA subgroup, ASDAS-CRP (1.98±0.19 to 1.71±0.15, p<0.05). There were no differences in the changes in ASDAS-CRP and BASDAI over the exercise training between groups (data not shown). After exercise therapy, positive changes of "Patients global assessment", were evaluated by patients of both subgroups, nr-ax-SpA (33.42±5.13 to 23.68±4.11, p<0.01) and AS (35.22±3.94 to 25.2±2.92, p<0.01). The "assessment of pain during the last 7 days", however, was improved only by patients in the nr-axSpA subgroup (34.74±5.88 vs. 21.05±4.71, p<0.05). The quality of life, ASQoL was not changed after rehabilitation programme.
The EurQoL was changed in all axSpA (0.74±0.21 to 0.77±0.18 p<0.05), but significantly was improved only in nr-axSpA subgroup (0.72±0.23 to 0.78±0.18, p<0.01), not AS. Similarly, the improvement of the assessment of "hodiernal health status" was found after an intervention only in the nr-axSpA subgroup (65.81±21.80 to 78.00±13.77, p<0.01). Conclusions: Our study demonstrated beneficial effect of intensive exercise programme on disease activity and patients self-reported outcomes in nr-axSpA and AS patients. The patients suffering from nr-axSpA can profit at least similarly from the rehabilitation care as those with radiographic form. The exercise programme should be recommended for both subtypes of axSpA. Background: Carpal tunnel syndrome (CTS) is the most common focal nerve entrapment; local corticosteroid (CS) injection has been widely used to treat CTS. Recently; Local insulin Injection in CTS has been studied as insulin has anti-inflammatory anti-edematous effects. Objectives: To compare the effectiveness of local steroid and insulin injections in management of CTS Methods: Forty patients complaining of mild or moderate idiopathic CTS (diagnosed clinically & electrophysiologically and classified according to American association of neuromuscular diagnostic medicine monograph) divided into 2 equal groups. Group I received two local injections of 10 IU NPH insulin into the affected carpal tunnel 2 weeks intervals. Group II: received single injection of triamcinolone acetonide (20 mg/0.5 ml) all procedures done after informed consent. Patients with severe or secondary type of CTS were excluded from this study. Evaluation of the patients was done at baseline, 2 and 4 months later clinically by measuring visual analogue scale (VAS), Phallen and compression tests and electrophysiologically by measuring motor and sensory nerve conduction studies of median and ulnar nerves using a standardized technique. Results: There was significant improvement in all clinical parameters in both groups after 2 and 4 months from injection (p<0.01) including VAS, Phallen and compression tests with more improvement was noticed in group I. Also there was significant improvement in electrophysiological parameters such as distal motor latency (DML) and distal sensory velocity of median nerve 2 and 4 months after treatment (p<0.01).However the improvement was more in group I but the difference between results in both groups were statistically nonsignificant. 
